Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
American Journal of Therapeutics(4)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Medicina Clinica(1)
Área de conocimiento
Enfermedad cardiovascular(2)
Nutrición(2)
Bioquímica(1)
Farmacología(1)
Fisiología(1)
Origen
scopus(6)
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype
Conference ObjectAbstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholesteroPalabras claves:Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, TriglyceridesAutores:Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusOat-derived β-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia
Conference ObjectAbstract: OBJECTIVE: To investigate the effect of bread formulated with 6 g of β-glucan (oat soluble fiber) onPalabras claves:HDL cholesterol, LDL cholesterol, LDL cholesterol/HDL cholesterol ratio, Non-HDL cholesterol, Oat soluble fiber, Total cholesterol/HDL cholesterol ratio, β-glucanAutores:Arias N., Arráiz N., Cano-Ponce C., Hernández-Hernandez R., Inglett G.E., Israili Z.H., Leal-Gonzalez E., Mengual-Moreno E., Reyna-Villasmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusMalondialdehide and reduced glutathione increase in patients with chronic stable ischaemic cardiopathy
ArticleAbstract: BACKGROUND AND OBJECTIVE: Cardiovascular diseases are associated with the ischemia/reperfusion phenoPalabras claves:Chronic ischemic heart disease, Coronary disease, Oxidation/antioxidationAutores:Bermúdez-Arias F., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Mengual-Moreno E., Valmore BermúdezFuentes:scopusPharmacologic treatment of obesity: Present, past and future
ReviewAbstract: Obesity is a chronic, stigmatized and costly disease that is rarely curable and is increasing in prePalabras claves:body mass index, Energetic balance, Noradrenegic agents, obesity, Orlistat, Serotoninergic agents, SibutraminAutores:Amell A., Bermúdez F.A., Cabrera M., Leal E.M., Mengual-Moreno E., Rodriguez M., Silva C., Toledo A., Valdelamar L., Valmore BermúdezFuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopus